ArticleMolecular cancer2025

Co-targeting of epigenetic regulators and BCL-XL improves efficacy of immune checkpoint blockade therapy in multiple solid tumors.

Yaiza Senent et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.